Denali Therapeutics Inc. (DNLI)

SEC filing

Denali Therapeutics Inc.

DNLI · CIK 1714899

4 · Sep 4, 2026 · Director Thornberry Nancy sold 11.44K shares at $22.90/share ($261.9K)

Director Thornberry Nancy sold 11.44K shares at $22.90/share ($261.9K)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.